New 24-Strain pneumonia vaccine trial launches for kids

NCT ID NCT07333352

Completed ⭐️ VACCINE ⭐️ Sponsor: Reinovax Biologics Co., LTD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study tests a new vaccine (RZ700) designed to protect infants and young children against 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. About 480 healthy children aged 6 weeks to 71 months will receive the vaccine to see if it triggers a strong immune response and is safe. The goal is to find a vaccine that covers more strains than current options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumococcal infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PNEUMOCOCCAL INFECTIOUS DISEASE

Contacts and locations

Locations

Jishan County Center for Disease Control and Prevention

Yuncheng, Shanxi, 043200, China
Kuangqu District Center for Disease Control and Prevention of Yangquan City

Yangquan, Shanxi, 045000, China
Luzhou District Center for Disease Control and Prevention

Changzhi, Shanxi, 046011, China
Qinxian County Center for Disease Control and Prevention

Changzhi, Shanxi, 046400, China
Shangdang District Center for Disease Control and Prevention of Changzhi City

Yuncheng, Shanxi, 047100, China
Xinjiang County Center for Disease Control and Prevention

Yuncheng, Shanxi, 043100, China
Yongji City Center for Disease Control and Prevention

Yuncheng, Shanxi, 044500, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.